Abstract
Despite being a relatively affluent nation, New Zealand (NZ) has persistently high rates of acute rheumatic fever (ARF) disproportionally affecting Māori and Pacific people. In 2011 the NZ government launched the Rheumatic Fever Prevention Programme (RFPP) with the stated aims of achieving equity of incidence and outcomes of ARF between Māori/Pacific and other NZ children, and to achieve a reduction in the national incidence of ARF by two-thirds, from 4.0 per 100,000 people in 2011 to 1.4 per 100,000 people by 2017. The three interventions of the RFPP are: (1) improve access to timely diagnosis and treatment for group A streptococcal pharyngitis; (2) increase awareness of ARF; and (3) reduce household crowding and transmission of group A streptococcus. The presentation will cover the epidemiology of ARF in NZ, and discuss issues arising from the RFPP and outcomes.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
